❮ Back to Researchers

Dan Werb

PhD

Scientist

Email: Daniel.Werb@unityhealth.to
Twitter: @dmwerb

Research Programs

Biography

Dan Werb, PhD, is an epidemiologist and policy analyst with expertise in overdose, Human Immunodeficiency Virus (HIV), addictions, and drug policy. Dr. Werb is a Research Scientist at the Li Ka Shing Knowledge Institute (LKSKI) at St. Michael’s Hospital in Toronto. He is also an Assistant Professor in the Division of Infectious Diseases & Global Public Health at the University of California, San Diego. Dr.Werb is Director of the Centre on Drug Policy Evaluation, a recognized global leader in cutting edge policy research and communications. Dr. Werb has published dozens of studies on issues related to health policy and addictions, with a focus on preventing the transition of street youth into injection drug use, as well as on identifying the impact of policy and public health interventions on street-based drug-using populations.

Please note: Dr. Werb is not taking any summer students.

 

Recent Publications

  1. Martignetti, L, Knight, R, Nafeh, F, Atkinson, K, Laurence, G, Johnson, CH et al.. Motivations for and perspectives of medication diversion among clients of a safer opioid supply program in Toronto, Canada. Int J Drug Policy. 2024;135 :104665. doi: 10.1016/j.drugpo.2024.104665. PubMed PMID:39637492 .
  2. Scheim, AI, Bouck, Z, Greenwald, ZR, Ling, V, Hopkins, S, Johnson, M et al.. Frequency of supervised consumption service use and acute care utilization in people who inject drugs. Drug Alcohol Depend. 2024;265 :112490. doi: 10.1016/j.drugalcdep.2024.112490. PubMed PMID:39546979 .
  3. Russell, C, Ali, F, Imtiaz, S, Butler, A, Greer, A, Rehm, J et al.. The decriminalization of illicit drugs in British Columbia: a national evaluation protocol. BMC Public Health. 2024;24 (1):2879. doi: 10.1186/s12889-024-20336-9. PubMed PMID:39425094 PubMed Central PMC11490149.
  4. Killion, JA, Jegede, OS, Werb, D, Davidson, PJ, Smith, LR, Gaines, T et al.. Modeling the impact of a supervised consumption site on HIV and HCV transmission among people who inject drugs in three counties in California, USA. Int J Drug Policy. 2024;132 :104557. doi: 10.1016/j.drugpo.2024.104557. PubMed PMID:39213827 .
  5. Kennedy, R, Bouck, Z, Werb, D, Kurmanalieva, A, Blyum, A, Shumskaya, N et al.. A cross-sectional assessment of injection of "salts" and HIV transmission-related behaviours among a cohort of people who inject drugs in Kyrgyzstan. J Int AIDS Soc. 2024;27 (7):e26247. doi: 10.1002/jia2.26247. PubMed PMID:38978392 PubMed Central PMC11231446.
  6. Mitra, S, Bouck, Z, Larney, S, Zolopa, C, Høj, S, Minoyan, N et al.. The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis. Harm Reduct J. 2024;21 (1):94. doi: 10.1186/s12954-024-00996-x. PubMed PMID:38750575 PubMed Central PMC11097551.
  7. Moran, L, Ondocsin, J, Outram, S, Ciccarone, D, Werb, D, Holm, N et al.. How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives. Harm Reduct J. 2024;21 (1):92. doi: 10.1186/s12954-024-01014-w. PubMed PMID:38734643 PubMed Central PMC11088080.
  8. Greenwald, ZR, Werb, D, Feld, JJ, Austin, PC, Fridman, D, Bayoumi, AM et al.. Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada. J Clin Epidemiol. 2024;170 :111332. doi: 10.1016/j.jclinepi.2024.111332. PubMed PMID:38522754 .
  9. Rammohan, I, Gaines, T, Scheim, A, Bayoumi, A, Werb, D. Overdose mortality incidence and supervised consumption services in Toronto, Canada: an ecological study and spatial analysis. Lancet Public Health. 2024;9 (2):e79-e87. doi: 10.1016/S2468-2667(23)00300-6. PubMed PMID:38307685 .
  10. Salvalaggio, G, Brooks, H, Caine, V, Gagnon, M, Godley, J, Houston, S et al.. Flawed reports can harm: the case of supervised consumption services in Alberta. Can J Public Health. 2023;114 (6):928-933. doi: 10.17269/s41997-023-00825-x. PubMed PMID:37930628 PubMed Central PMC10661131.
Search PubMed

Affiliations & Other Activities

  • Assistant Professor, Division of Global Public Health, University of California San Diego Director, International Centre for Science in Drug Policy